Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why pharma giant Roche is putting German investments on hold
Swiss pharmaceutical giant Roche said on Monday it would put expansion in Germany on hold, dealing a blow to Berlin as a government-backed investment summit got underway. 'We have put all future investment decisions in Germany on hold for the time…
Trump Dangles $100 Million Kentucky Pharma Investment, But Only If Republicans Win Midterms
President Donald Trump announced plans for the Department of War to invest $100 million to support a pharmaceutical company, with the offer conditional on Republicans winning the midterm elections next month. Antheia would receive the funds to…
China's Hansoh Pharma Scores Drug Deal with Roche Worth over $15 Billion
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann China's Hansoh Pharmaceutical said on Monday its units have entered into a partnership and licensing deal with Roche…
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion
By Thomson Reuters Oct 19, 2026 | 6:30 AM Oct 19 (Reuters) – China's Hansoh Pharmaceutical said on Monday its units have entered into a partnership and licensing deal with Roche, potentially worth more than $15 billion, that…
Natco Pharma launches generic cancer drug Carboplatin in US
Drug maker Natco Pharma on Monday announced the launch of Carboplatin Injection in the US market through its subsidiary Natco Pharma USA LLC. The product, a generic version of Paraplatin, has been launched in manufacturing collaboration with…
BridgeBio Pharma (NASDAQ:BBIO) Given New $91.00 Price Target at Citigroup
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price reduced by analysts at Citigroup from $94.00 to $91.00 in a report released on Monday, Benzinga reports. The firm currently has a 'neutral' rating on the stock. Citigroup's…
Avalyn Pharma Inc.'s Lock-Up Period Set To End on October 27th (NASDAQ:AVLN)
Avalyn Pharma's (NASDAQ:AVLN - Get Free Report) lock-up period will expire on Tuesday, October 27th. Avalyn Pharma had issued 16,666,667 shares in its public offering on April 30th. The total size of the offering was $300,000,006 based on an…
Goldman Sachs flags 23 defensive stocks to own as the economy slows and the bull market struggles
Buckle up for a more challenging year ahead of the US stock market, Goldman Sachs says. The Wall Street bank warned of a more troubled backdrop for stocks heading into 2027, issuing its top recommendations for investors in the evolving macro…
Smithfield Foods: Holding On As Pork Industry Goes Through A Challenging Cycle (SFD)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
RFK Jr. Blames Measles Outbreak on Missed Vaccinations After Years of Warning About MMR Risks
For years, Robert F. Kennedy Jr. championed families whose children were injured by the measles, mumps, and rubella (MMR) vaccine. He challenged federal health agencies and Big Pharma, popularized censored research, and co-authored a book exposing…
Big Pharma's Body Count: Prescription Drugs Now the Leading Cause of Death, Surpassing Heart Disease and Cancer
A landmark re-analysis of drug mortality data has delivered a verdict the medical establishment has spent decades avoiding: pharmaceuticals have overtaken heart disease and cancer to become the single leading cause of death. Our prescription drugs…
JPMorgan Chase's security and resiliency initiative facilitates $230B of investment in first year (JPM:NYSE)
JPMorgan Chase (JPM) has financed and facilitated more than $230B to help strengthen industries, supply chains, and technologies that support long-term national security and economic resilience one year into the firm's 10-year $1.5T Security and…
Healthcare is catching the rotation out of AI. Josh Brown's list includes two names that can benefit
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — Money doesn't leave the market. It moves, and the list is where we see it first. The Best Stocks in the Market list is…
MDMA (Molly) for PTSD: Hope, Hype, and Hard Evidence
A review/meta-analysis found MDMA-assisted therapy improves PTSD symptoms, but evidence certainty is low. Positive trials establish lasting remission, adequate safety, and effectiveness in ordinary clinical practice. VA and independent…
There's still hope for TotalEnergies as UCI announces team registrations for 2027
The number of men's ProTeams has shrunk by two, but the women's grew by one, and the men's and women's WorldTour teams should all be in the peloton in 2027, as the UCI announced the number of teams that have met the registration deadline of October…
Receive a Daily briefing on Pharma Industry News
Get Started